Efficacy and safety of modified-dose obinutuzumab in the treatment of refractory membranous nephropathy.
Saved in:
| Title: | Efficacy and safety of modified-dose obinutuzumab in the treatment of refractory membranous nephropathy. |
|---|---|
| Authors: | Zhou J; Department of Nephrology, Beijing Aerospace General Hospital, Beijing, China., Ai S; Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Zhang X; Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China., Wang X; Department of Nephrology, Beijing Aerospace General Hospital, Beijing, China., Chen G; Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Wang Y; Department of Nephrology, Beijing Aerospace General Hospital, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 22; Vol. 17, pp. 1787013. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1787013 |
